Procaps Group SA Valuation
| PROCDelisted Stock | USD 1.10 0.00 0.00% |
Today, the company appears to be overvalued. Procaps Group SA holds a recent Real Value of $1.01 per share. The prevailing price of the company is $1.1. Our model determines the value of Procaps Group SA from analyzing the company fundamentals such as Return On Equity of 0.37, operating margin of 0.11 %, and Shares Outstanding of 112.82 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Procaps Group's price fluctuation is very steady at this time. Calculation of the real value of Procaps Group SA is based on 3 months time horizon. Increasing Procaps Group's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Procaps Group is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Procaps Stock. However, Procaps Group's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.1 | Real 1.01 | Hype 1.1 | Naive 1.3 |
The real value of Procaps Stock, also known as its intrinsic value, is the underlying worth of Procaps Group SA Company, which is reflected in its stock price. It is based on Procaps Group's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Procaps Group's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Procaps Group SA helps investors to forecast how Procaps stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Procaps Group more accurately as focusing exclusively on Procaps Group's fundamentals will not take into account other important factors: About Procaps Group Valuation
The delisted stock valuation mechanism determines Procaps Group's current worth on a weekly basis. Our valuation model uses a comparative analysis of Procaps Group. We calculate exposure to Procaps Group's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Procaps Group's related companies.Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company was founded in 1977 and is based in Luxembourg, Luxembourg. Procaps Group is traded on NASDAQ Exchange in the United States.
Procaps Group Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 101.1 M | |
| Quarterly Earnings Growth Y O Y | -0.637 | |
| Forward Price Earnings | 81.3008 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in Procaps Stock
If you are still planning to invest in Procaps Group SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Procaps Group's history and understand the potential risks before investing.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |